カテゴリ： Grand View Research, 世界, 医療/バイオ

コンチネンスケアのグローバル市場2023-2030：尿道カテーテル、尿バッグ

■ 英語タイトル：Continence Care Market Size, Share & Trends Analysis Report By Product (Urinary Catheters, Urinary Bags), By Bag Usage (Sterile Bags, Non-sterile Bags), By Application (Diabetes, BPH), By End-use, By Region, And Segment Forecasts, 2023 - 2030

調査会社Grand View Research社が発行したリサーチレポート（データ管理コード：GRV23NOV082）■ 発行会社/調査会社：Grand View Research
■ 商品コード：GRV23NOV082
■ 発行日：2023年9月
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：121
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール
■ 販売価格オプション（消費税別）
Single UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD7,950 ⇒換算￥1,208,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD9,950 ⇒換算￥1,512,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[コンチネンスケアのグローバル市場2023-2030：尿道カテーテル、尿バッグ]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

コンチネンスケア市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界のコンチネンスケア市場規模は、2023年から2030年までの年平均成長率が5.5%で、2030年までに34.9億米ドルに達すると予測されています。大腸がんや膀胱がん、脳卒中、糖尿病など、さまざまな慢性疾患の有病率の増加しました。技術の進歩、様々なヘルスケアや在宅ケアの現場における無菌製品の需要の増加、ライフスタイルの変化、高齢者人口の増加が市場成長の主な要因です。

高血圧と糖尿病の有病率の上昇は、尿失禁（UI）を引き起こす主な要因の1つであり、コンチネンスケア製品の需要を世界的に牽引しています。例えば、WHOが2023年に発表した報告書によると、世界全体で約12.8億人が高血圧に苦しんでいます。その結果、関連疾患を患う患者数が増加し、コンチネンスケア製品の需要が急増する見込みです。

米国のコンチネンスケア業界で事業を展開している企業には、Coloplast、Hollister Incorporated、Convatec Groupなどがあります。これらの企業は幅広い製品と消耗品を提供し、製品の品質、価格、技術革新、流通網などの要因に基づいて競争しています。

コンチネンスケア市場レポートハイライト

- 製品別では、膀胱癌、前立腺癌、膀胱制御障害などの慢性疾患の有病率の増加により、尿道カテーテル分野が2022年の市場シェアを52.5%で独占しました。

- 用途別では、糖尿病および糖尿病関連UIの世界的な有病率の増加により、糖尿病分野が25.5%のシェアで2022年の市場を独占しました。

- バッグの用途別では、2022年に無菌バッグ分野が64.9%と圧倒的な市場シェアを占め、予測期間中も堅調な成長が見込まれています。

- 在宅介護および患者中心の医療サービスにおけるコンチネンスケア製品の需要増加により、2022年のエンドユーザー市場全体の43.0%を占めたのは在宅介護環境分野です。

- 欧州は、クローン病および潰瘍性大腸炎の罹患率が高いことから、2022年の世界市場で48.5%の売上高シェアを占めました。Journal of Crohn's and Colitisによると、欧州の総人口の0.3%がIBDに罹患しています。

第1章 調査方法・範囲
第2章 エグゼクティブサマリー
第3章 世界のコンチネンスケア市場変数・傾向・範囲
第4章 世界のコンチネンスケア市場：製品別予測・傾向分析
第5章 世界のコンチネンスケア市場：用途別予測・傾向分析
第6章 世界のコンチネンスケア市場：バッグ使用別予測・傾向分析
第7章 世界のコンチネンスケア市場：エンドユーザー別予測・傾向分析
第8章 世界のコンチネンスケア市場：地域別予測・傾向分析
第9章 競争状況

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Application
1.1.3. Bag usage
1.1.4. End-user
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. Bag usage outlook
2.2.4. End-user outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Continence Care Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of Urinary Incontinence (UI)
3.2.1.2. Growing geriatric population
3.2.1.3. Rapid technological advancements
3.2.1.4. Rise in demand for minimally invasive procedures
3.2.2. Market restraint analysis
3.2.2.1. Growing concerns regarding Catheter-Associated Urinary Tract Infection (CAUTI)
3.2.3. Market opportunity analysis
3.2.3.1. Presence of online platform
3.2.3.2. Increase in the initiatives to raise incontinence awareness worldwide
3.3. Continence Care Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Covid-19 Impact Analysis
Chapter 4. Continence Care Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Urinary Catheters
4.1.2. Catheter Maintenance/Care
4.1.3. Urinary Bags
4.1.4. Incontinence and Bowel Management
4.2. Product Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. Global Surgical Refractor Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
4.5.1. Urinary Catheters
4.5.1.1. Urinary Catheters market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.2. Intermittent Catheters
4.5.1.2.1 Intermittent catheters market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.2.2 Female
4.5.1.2.2.1 Female market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.2.3 Male
4.5.1.2.3.1 Male market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.3. Intermittent Catheter Sets
4.5.1.3.1 Intermittent catheter sets market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.3.2 Female
4.5.1.3.2.1 Female market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.3.3 Male
4.5.1.3.3.1 Male market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.4 Intermittent Catheters Dry
4.5.1.4.1 Intermittent catheters dry market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.5 Indwelling Foley Catheters Silicone
4.5.1.5.1 Indwelling foley catheters silicone market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.5.2 2W
4.5.1.5.2.1 2W market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.5.3 3W
4.5.1.5.3.1 3W market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Catheter Maintenance/Care
4.5.2.1. Catheter Maintenance/Care market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Urinary Bags
4.5.3.1. Urinary Bags market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.2. Pediatric urine bags
4.5.3.2.1 Pediatric urine bags market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.3. Night bags > 1,5L
4.5.3.3.1 Night bags > 1,5L market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.3.2 Sterile
4.5.3.3.2.1 Sterile market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.3.3 Non-Sterile
4.5.3.3.3.1 Non-Sterile market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.4 Bag accessories
4.5.3.4.1 Bag accessories market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.5 Leg urine bags < 1,5L 4.5.3.5.1 Leg urine bags < 1,5L market estimates and forecast 2018 to 2030 (USD Million) 4.5.3.5.2 Sterile 4.5.2.5.2.1 Sterile market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.5.3 Non-Sterile 4.5.3.5.3.1 Non-Sterile market estimates and forecast 2018 to 2030 (USD Million) 4.5.4. Incontinence and Bowel Management 4.5.4.1. Incontinence and Bowel Management market estimates and forecast 2018 to 2030 (USD Million) 4.5.4.2. Male external catheters silicone 4.5.4.2.1 Male external catheters silicone market estimates and forecast 2018 to 2030 (USD Million) 4.5.4.3. Female incontinence device 4.5.4.3.1 Female incontinence device market estimates and forecast 2018 to 2030 (USD Million) 4.5.4.4. Irrigation pump/Transanal irrigation 4.5.4.4.1 Irrigation pump/Transanal irrigation market estimates and forecast 2018 to 2030 (USD Million) Chapter 5. Continence Care Market: Application Estimates & Trend Analysis 5.1. Definitions and Scope 5.1.1. Diabetes 5.1.2. Strokes 5.1.3. Benign Prostatic Hyperplasia (BPH) 5.1.4. Alzheimer 5.1.5. Cerebral Palsy 5.1.6. Parkinson 5.1.7. Prostate Cancer 5.1.8. Spinal Cord Injury 5.1.9. Bladder Cancer 5.1.10. Multiple Sclerosis 5.1.11. Spina Bifida 5.1.12. Others 5.2. Application Market Share, 2018 & 2030 5.3. Segment Dashboard 5.4. Global Continence Care Market by Application Outlook 5.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following 5.5.1. Diabetes 5.5.1.1. Diabetes market estimates and forecast 2018 to 2030 (USD Million) 5.5.2. Strokes 5.5.2.1. Strokes market estimates and forecast 2018 to 2030 (USD Million 5.5.3. Benign Prostatic Hyperplasia (BPH) 5.5.3.1. Benign Prostatic Hyperplasia (BPH) market estimates and forecast 2018 to 2030 (USD Million) 5.5.4. Alzheimer 5.5.4.1. Alzheimer market estimates and forecast 2018 to 2030 (USD Million) 5.5.5. Cerebral Palsy) 5.5.5.1. Cerebral palsy market estimates and forecast 2018 to 2030 (USD Million) 5.5.6. Parkinson 5.5.6.1. Parkinson market estimates and forecast 2018 to 2030 (USD Million) 5.5.7. Prostate cancer 5.5.7.1. Prostate cancer market estimates and forecast 2018 to 2030 (USD Million) 5.5.8. Spinal Cord Injury 5.5.8.1. Spinal cord injury market estimates and forecast 2018 to 2030 (USD Million) 5.5.9. Bladder cancer 5.5.9.1. Bladder cancer market estimates and forecast 2018 to 2030 (USD Million) 5.5.10. Multiple sclerosis 5.5.10.1. Multiple sclerosis market estimates and forecast 2018 to 2030 (USD Million) 5.5.11. Spina Bifida 5.5.11.1. Spina Bifida market estimates and forecast 2018 to 2030 (USD Million) 5.5.12. Others 5.5.12.1. Others market estimates and forecast 2018 to 2030 (USD Million) Chapter 6. Continence Care: Bag Usage Estimates & Trend Analysis 6.1. Definitions and Scope 6.1.1. Sterile 6.1.2. Non-Sterile 6.2. Bag Usage Market Share, 2018 & 2030 6.3. Segment Dashboard 6.4. Global Continence Care Market by Bag Usage Outlook 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 6.5.1. Sterile 6.5.1.1. Sterile market estimates and forecast 2018 to 2030 (USD Million) 6.5.2. Non-Sterile 6.5.2.1. Non-sterile market estimates and forecast 2018 to 2030 (USD Million) Chapter 7. Continence Care: End-use Estimates & Trend Analysis 7.1. Definitions and Scope 7.1.1. Home Care Settings 7.1.2. Hospitals 7.1.3. Others 7.2. End-use Market Share, 2018 & 2030 7.3. Segment Dashboard 7.4. Global Continence Care Market by End-use Outlook 7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 7.5.1. Home Care Settings 7.5.1.1. Home care settings market estimates and forecast 2018 to 2030 (USD Million) 7.5.2. Hospitals 7.5.2.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million) 7.5.3. Others 7.5.3.1. Others market estimates and forecast 2018 to 2030, (USD Million) Chapter 8. Continence Care Market: Regional Estimates & Trend Analysis 8.1. Regional market share analysis, 2022 & 2030 8.2. Regional Market Dashboard 8.3. Global Regional Market Snapshot 8.4. Regional Market Share and Leading Players, 2022 8.4.1. North America 8.4.2. Europe 8.4.3. Asia Pacific 8.4.4. Latin America 8.4.5. Middle East and Africa 8.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030: 8.6. North America 8.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 8.6.2. U.S. 8.6.2.1. Key country dynamics 8.6.2.2. Competitive Scenario 8.6.2.3. Regulatory framework 8.6.2.4. Reimbursement scenario 8.6.2.5. U.S. market estimates and forecasts, 2018 - 2030 8.6.3. Canada 8.6.3.1. Key country dynamics 8.6.3.2. Competitive Scenario 8.6.3.3. Regulatory framework 8.6.3.4. Reimbursement scenario 8.6.3.5. Canada market estimates and forecasts, 2018 - 2030 8.7. Europe 8.7.1. France with DOM-TOM 8.7.1.1. Key country dynamics 8.7.1.2. Competitive Scenario 8.7.1.3. Regulatory framework 8.7.1.4. Reimbursement scenario 8.7.1.5. France with DOM-TOM market estimates and forecasts, 2018 - 2030 8.7.2. UK 8.7.2.1. Key country dynamics 8.7.2.2. Competitive Scenario 8.7.2.3. Regulatory framework 8.7.2.4. Reimbursement scenario 8.7.2.5. UK market estimates and forecasts, 2018 - 2030 8.7.3. Spain 8.7.3.1. Key country dynamics 8.7.3.2. Competitive Scenario 8.7.3.3. Regulatory framework 8.7.3.4. Reimbursement scenario 8.7.3.5. Spain market estimates and forecasts, 2018 - 2030 8.7.4. Italy 8.7.4.1. Key country dynamics 8.7.4.2. Competitive Scenario 8.7.4.3. Regulatory framework 8.7.4.4. Reimbursement scenario 8.7.4.5. Italy market estimates and forecasts, 2018 - 2030 8.7.5. Portugal 8.7.5.1. Key country dynamics 8.7.5.2. Competitive Scenario 8.7.5.3. Regulatory framework 8.7.5.4. Reimbursement scenario 8.7.5.5. Portugal market estimates and forecasts, 2018 - 2030 8.7.6. Netherlands 8.7.6.1. Key country dynamics 8.7.6.2. Competitive Scenario 8.7.6.3. Regulatory framework 8.7.6.4. Reimbursement scenario 8.7.6.5. Netherlands market estimates and forecasts, 2018 - 2030 8.7.7. Ireland 8.7.7.1. Key country dynamics 8.7.7.2. Competitive Scenario 8.7.7.3. Regulatory framework 8.7.7.4. Reimbursement scenario 8.7.7.5. Ireland market estimates and forecasts, 2018 - 2030 8.7.8. Belgium 8.7.8.1. Key country dynamics 8.7.8.2. Competitive Scenario 8.7.8.3. Regulatory framework 8.7.8.4. Reimbursement scenario 8.7.8.5. Belgium market estimates and forecasts, 2018 - 2030 8.7.9. Switzerland 8.7.9.1. Key country dynamics 8.7.9.2. Competitive Scenario 8.7.9.3. Regulatory framework 8.7.9.4. Reimbursement scenario 8.7.9.5. Switzerland market estimates and forecasts, 2018 - 2030 8.7.10. Denmark 8.7.10.1. Key country dynamics 8.7.10.2. Competitive Scenario 8.7.10.3. Regulatory framework 8.7.10.4. Reimbursement scenario 8.7.10.5. Denmark market estimates and forecasts, 2018 - 2030 8.7.11. Sweden 8.7.11.1. Key country dynamics 8.7.11.2. Competitive Scenario 8.7.11.3. Regulatory framework 8.7.11.4. Reimbursement scenario 8.7.11.5. Sweden market estimates and forecasts, 2018 - 2030 8.7.12. Finland 8.7.12.1. Key country dynamics 8.7.12.2. Competitive Scenario 8.7.12.3. Regulatory framework 8.7.12.4. Reimbursement scenario 8.7.12.5. Finland market estimates and forecasts, 2018 - 2030 8.7.13. Norway 8.7.13.1. Key country dynamics 8.7.13.2. Competitive Scenario 8.7.13.3. Regulatory framework 8.7.13.4. Reimbursement scenario 8.7.13.5. Norway market estimates and forecasts, 2018 - 2030 8.7.14. Czech Republic 8.7.14.1. Key country dynamics 8.7.14.2. Competitive Scenario 8.7.14.3. Regulatory framework 8.7.14.4. Reimbursement scenario 8.7.14.5. Czech Republic market estimates and forecasts, 2018 - 2030 8.7.15. Russian Federation 8.7.15.1. Key country dynamics 8.7.15.2. Competitive Scenario 8.7.15.3. Regulatory framework 8.7.15.4. Reimbursement scenario 8.7.15.5. Russian Federation market estimates and forecasts, 2018 - 2030 8.7.16. Poland 8.7.16.1. Key country dynamics 8.7.16.2. Competitive Scenario 8.7.16.3. Regulatory framework 8.7.16.4. Reimbursement scenario 8.7.16.5. Poland market estimates and forecasts, 2018 - 2030 8.7.17. Austria 8.7.17.1. Key country dynamics 8.7.17.2. Competitive Scenario 8.7.17.3. Regulatory framework 8.7.17.4. Reimbursement scenario 8.7.17.5. Austria market estimates and forecasts, 2018 - 2030 8.7.18. Romania 8.7.18.1. Key country dynamics 8.7.18.2. Competitive Scenario 8.7.18.3. Regulatory framework 8.7.18.4. Reimbursement scenario 8.7.18.5. Romania market estimates and forecasts, 2018 - 2030 8.7.19. Slovakia 8.7.19.1. Key country dynamics 8.7.19.2. Competitive Scenario 8.7.19.3. Regulatory framework 8.7.19.4. Reimbursement scenario 8.7.19.5. Slovakia market estimates and forecasts, 2018 - 2030 8.7.20. Slovenia 8.7.20.1. Key country dynamics 8.7.20.2. Competitive Scenario 8.7.20.3. Regulatory framework 8.7.20.4. Reimbursement scenario 8.7.20.5. Slovenia market estimates and forecasts, 2018 - 2030 8.7.21. Serbia 8.7.21.1. Key country dynamics 8.7.21.2. Competitive Scenario 8.7.21.3. Regulatory framework 8.7.21.4. Reimbursement scenario 8.7.21.5. Serbia market estimates and forecasts, 2018 - 2030 8.7.22. Greece 8.7.22.1. Key country dynamics 8.7.22.2. Competitive Scenario 8.7.22.3. Regulatory framework 8.7.22.4. Reimbursement scenario 8.7.22.5. Greece market estimates and forecasts, 2018 - 2030 8.7.23. Turkey 8.7.23.1. Key country dynamics 8.7.23.2. Competitive Scenario 8.7.23.3. Regulatory framework 8.7.23.4. Reimbursement scenario 8.7.23.5. Turkey market estimates and forecasts, 2018 - 2030 8.7.24. Ukraine 8.7.24.1. Key country dynamics 8.7.24.2. Competitive Scenario 8.7.24.3. Regulatory framework 8.7.24.4. Reimbursement scenario 8.7.24.5. Ukraine market estimates and forecasts, 2018 - 2030 8.8. Asia Pacific 8.8.1. Japan 8.8.1.1. Key country dynamics 8.8.1.2. Competitive Scenario 8.8.1.3. Regulatory framework 8.8.1.4. Reimbursement scenario 8.8.1.5. Japan market estimates and forecasts, 2018 - 2030 8.8.2. India 8.8.2.1. Key country dynamics 8.8.2.2. Competitive Scenario 8.8.2.3. Regulatory framework 8.8.2.4. Reimbursement scenario 8.8.2.5. India market estimates and forecasts, 2018 - 2030 8.8.3. China 8.8.3.1. Key country dynamics 8.8.3.2. Competitive Scenario 8.8.3.3. Regulatory framework 8.8.3.4. Reimbursement scenario 8.8.3.5. China market estimates and forecasts, 2018 - 2030 8.8.4. South Korea 8.8.4.1. Key country dynamics 8.8.4.2. Competitive Scenario 8.8.4.3. Regulatory framework 8.8.4.4. Reimbursement scenario 8.8.4.5. South Korea market estimates and forecasts, 2018 - 2030 8.8.5. Australia 8.8.5.1. Key country dynamics 8.8.5.2. Competitive Scenario 8.8.5.3. Regulatory framework 8.8.5.4. Reimbursement scenario 8.8.5.5. Australia market estimates and forecasts, 2018 - 2030 8.8.6. Thailand 8.8.6.1. Key country dynamics 8.8.6.2. Competitive Scenario 8.8.6.3. Regulatory framework 8.8.6.4. Reimbursement scenario 8.8.6.5. Thailand market estimates and forecasts, 2018 - 2030 8.8.7. Malaysia 8.8.7.1. Key country dynamics 8.8.7.2. Competitive Scenario 8.8.7.3. Regulatory framework 8.8.7.4. Reimbursement scenario 8.8.7.5. Thailand market estimates and forecasts, 2018 - 2030 8.9. Latin America 8.9.1. Brazil 8.9.1.1. Key country dynamics 8.9.1.2. Competitive Scenario 8.9.1.3. Regulatory framework 8.9.1.4. Reimbursement scenario 8.9.1.5. Brazil market estimates and forecasts, 2018 - 2030 8.9.2. Chile 8.9.2.1. Key country dynamics 8.9.2.2. Competitive Scenario 8.9.2.3. Regulatory framework 8.9.2.4. Reimbursement scenario 8.9.2.5. Chile market estimates and forecasts, 2018 - 2030 8.9.3. Colombia 8.9.3.1. Key country dynamics 8.9.3.2. Competitive Scenario 8.9.3.3. Regulatory framework 8.9.3.4. Reimbursement scenario 8.9.3.5. Colombia market estimates and forecasts, 2018 - 2030 8.9.4. Argentina 8.9.4.1. Key country dynamics 8.9.4.2. Competitive Scenario 8.9.4.3. Regulatory framework 8.9.4.4. Reimbursement scenario 8.9.4.5. Argentina market estimates and forecasts, 2018 - 2030 8.10. MEA 8.10.1. South Africa 8.10.1.1. Key country dynamics 8.10.1.2. Competitive Scenario 8.10.1.3. Regulatory framework 8.10.1.4. Reimbursement scenario 8.10.1.5. South Africa market estimates and forecasts, 2018 - 2030 8.10.2. Saudi Arabia 8.10.2.1. Key country dynamics 8.10.2.2. Competitive Scenario 8.10.2.3. Regulatory framework 8.10.2.4. Reimbursement scenario 8.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030 8.10.3. UAE 8.10.3.1. Key country dynamics 8.10.3.2. Competitive Scenario 8.10.3.3. Regulatory framework 8.10.3.4. Reimbursement scenario 8.10.3.5. UAE market estimates and forecasts, 2018 - 2030 8.10.4. Kuwait 8.10.4.1. Key country dynamics 8.10.4.2. Competitive Scenario 8.10.4.3. Regulatory framework 8.10.4.4. Reimbursement scenario 8.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030 Chapter 9. Competitive Landscape 9.1. Recent Developments & Impact Analysis, By Key Market Participants 9.2. Company/Competition Categorization 9.2.1. Innovators 9.3. Vendor Landscape 9.3.1. List of key distributors and channel partners 9.3.2. Key customers 9.3.3. Key company market share analysis, 2022 9.3.4. Coloplast Group 9.3.4.1. Company overview 9.3.4.2. Financial performance 9.3.4.3. Product benchmarking 9.3.4.4. Strategic initiatives 9.3.5. Convatec Group PLC 9.3.5.1. Company overview 9.3.5.2. Financial performance 9.3.5.3. Product benchmarking 9.3.5.4. Strategic initiatives 9.3.6. Hollister Incorporated 9.3.6.1. Company overview 9.3.6.2. Financial performance 9.3.6.3. Product benchmarking 9.3.6.4. Strategic initiatives 9.3.7. B. Braun SE 9.3.7.1. Company overview 9.3.7.2. Financial performance 9.3.7.3. Product benchmarking 9.3.7.4. Strategic initiatives 9.3.8. BD 9.3.8.1. Company overview 9.3.8.2. Financial performance 9.3.8.3. Product benchmarking 9.3.8.4. Strategic initiatives 9.3.9. Wellspect HealthCare 9.3.9.1. Company overview 9.3.9.2. Financial performance 9.3.9.3. Product benchmarking 9.3.9.4. Strategic initiatives 9.3.10. Salts Healthcare Ltd. 9.3.10.1. Company overview 9.3.10.2. Financial performance 9.3.10.3. Product benchmarking 9.3.10.4. Strategic initiatives 9.3.11. Welland Medical Ltd. 9.3.11.1. Company overview 9.3.11.2. Financial performance 9.3.11.3. Product benchmarking 9.3.11.4. Strategic initiatives



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ウェアラブルインジェクターのグローバル市場2024-2030：オンボディ、オフボディ
  • 医療用特殊バッグのグローバル市場2024-2028：オストミー用バッグ、輸液バッグ、CAPDバッグ、尿バッグ
  • 尿失禁デバイスのグローバル市場：尿道カテーテル、膣スリング、電気刺激デバイス、人工尿道括約筋、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GRV23NOV082 )"コンチネンスケアのグローバル市場2023-2030：尿道カテーテル、尿バッグ" (英文：Continence Care Market Size, Share & Trends Analysis Report By Product (Urinary Catheters, Urinary Bags), By Bag Usage (Sterile Bags, Non-sterile Bags), By Application (Diabetes, BPH), By End-use, By Region, And Segment Forecasts, 2023 - 2030)はGrand View Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。